首页>
外国专利>
method for preparation of a preparation method for the preparation of a compound vascoludilatatoire operation suitable for use in this method
method for preparation of a preparation method for the preparation of a compound vascoludilatatoire operation suitable for use in this method
展开▼
机译:制备方法,用于制备适用于该方法的复合血管结肠手术的制备方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
1455502 Amino-esters derived from 2,6-dialkyl - 4 - phenyl - 4,4 - dihydropyridines YAMANOUCHI PHARMACEUTICAL CO Ltd 11 Feb 1974 [20 Feb 1973 3 March 1973 20 April 1973 11 May 1973 17 May 1973 24 July 1973 29 Nov 1973 (2)] 06045/74 Heading C2C The invention comprises compounds of formula and their non-toxic salts, wherein R and RSP4/SP are each H or alkyl; RSP1/SP and RSP2/SP are each alkyl; RSP3/SP is (possibly substituted) Ph or aralkyl; RSP5/SP is alkyl, alkoxy, alkoxyalkoxy or RSP6/SP is NO 2 or CF 3 ; and A is alkylene, each of the foregoing alkyl, alkoxy and alkylene groups containing 1-6 C atoms. In examples, these compounds are prepared by (1) reacting together RSP6/SPC 6 H 4 CHO, an ester (A) of the acid and an ester (B) of the acid RSP1/SPC(NR) : CHCO 2 H, one of these esters being esterified with RSP5/SPOH and the other with RSP3/SPRSP4/SPNAOH, with the following possible variations-(a) ester (B) may be formed in situ from ester (A) and RNH 2 , (b) the RSP6/SPC 6 H 4 CHO and ester (A) may be replaced by a corresponding ester of (2) reacting HNRSP3/SPRSP4/SP with (e.g.) the methyl or isopropyl ester of 3-(2-chloroethoxycarbonyl)-2,6- dimethyl - 4 - (3 - nitrophenyl) - 1,4 - dihydropyridine-5-carboxylic acid Therapeutic compositions having musculotropic spasmolytic and cerebral vascular dilator activity comprise compounds of the above formula and may be administered orally and parenterally.
展开▼
机译:1455502由2,6-二烷基-4-苯基-4,4-二氢吡啶衍生的氨基酯YAMANOUCHI PHARMACEUTICAL CO Ltd 1974年2月11日[1973年2月20日1973年3月3日1973年4月20日1973年5月11日1973年5月17日1973年7月24日1973年11月29日(2)06045/74标题C2C本发明包括下式的化合物及其无毒盐,其中R和R SP 4分别为H或烷基; R 1 SP>和R 2 SP>分别为烷基; R 3 SP>是(可能被取代的)Ph或芳烷基; R 5 SP>是烷基,烷氧基,烷氧基烷氧基或R 6 SP>是NO 2或CF 3; A为亚烷基,上述烷基,烷氧基和亚烷基均含有1-6个碳原子。在实施例中,这些化合物是通过(1)将R SP 6 C 6 H 4 CHO,酸的酯(A)和酸RSP1的酯(B)反应而制备的。 SP> C(NR):CHCO 2 H,其中一种酯被R 5 SP> OH酯化,另一种酯被R 3 SP> R 4 酯> SP> NAOH,具有以下可能的变化-(a)酯(B)可以由酯(A)和RNH 2原位形成,(b)R 6 SP> C 6 H 4 CHO和酯(A)可用(2)使HNR 3 SP> R 4 SP>与3-(2-氯乙氧基羰基)的甲基或异丙基酯反应的相应酯代替)-2,6-二甲基-4-(3-硝基苯基)-1,4-二氢吡啶-5-羧酸具有肌肉溶血性和脑血管扩张剂活性的治疗组合物包含上式的化合物,并且可以口服和肠胃外给药。
展开▼